Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimum Treatment for Drug-Resistant Hypertension

NCT02369081 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT02369081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02369081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimum Treatment for Drug-Resistant Hypertension
Lead sponsor
University of Cambridge
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2009
Completion date
August 31, 2015
Enrollment
348 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, resistant to conventional therapy